12/20
06:12 am
brkr
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility [Yahoo! Finance]
Medium
Report
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility [Yahoo! Finance]
12/20
06:00 am
brkr
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility
Medium
Report
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility
12/19
09:09 am
brkr
Bruker Co. (NASDAQ: BRKR) is now covered by analysts at Guggenheim. They set a "buy" rating and a $72.00 price target on the stock.
Low
Report
Bruker Co. (NASDAQ: BRKR) is now covered by analysts at Guggenheim. They set a "buy" rating and a $72.00 price target on the stock.
12/16
07:10 am
brkr
PET/CT System Market is Projected to Reach US$ 5.27 Billion, Growing at 6.1% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]
Low
Report
PET/CT System Market is Projected to Reach US$ 5.27 Billion, Growing at 6.1% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]
12/13
11:16 am
brkr
Bruker Co. (NASDAQ: BRKR) had its price target raised by analysts at Bank of America Co. from $78.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
Bruker Co. (NASDAQ: BRKR) had its price target raised by analysts at Bank of America Co. from $78.00 to $80.00. They now have a "buy" rating on the stock.
12/10
08:58 am
brkr
Bruker Co. (NASDAQ: BRKR) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $66.00 price target on the stock.
Low
Report
Bruker Co. (NASDAQ: BRKR) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $66.00 price target on the stock.
12/5
04:00 pm
brkr
IonOpticks' Custom Chromatography Column to Become Biognosys' Standard for High-Quality Proteomic Insights
Low
Report
IonOpticks' Custom Chromatography Column to Become Biognosys' Standard for High-Quality Proteomic Insights
12/5
08:01 am
brkr
Bruker Co. (NASDAQ: BRKR) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $60.00 price target on the stock.
Low
Report
Bruker Co. (NASDAQ: BRKR) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $60.00 price target on the stock.
12/3
04:55 am
brkr
Medical Image Analysis Software Research Report 2024: Global Market to Reach $8.3 Billion by 2030 - Multi-modality Image Analysis Systems Expands Opportunities [Yahoo! Finance]
Low
Report
Medical Image Analysis Software Research Report 2024: Global Market to Reach $8.3 Billion by 2030 - Multi-modality Image Analysis Systems Expands Opportunities [Yahoo! Finance]
12/2
07:10 am
brkr
Bruker Introduces Dimension Nexus™ Atomic Force Microscope [Yahoo! Finance]
Low
Report
Bruker Introduces Dimension Nexus™ Atomic Force Microscope [Yahoo! Finance]
12/2
07:00 am
brkr
Bruker Introduces Dimension Nexus™ Atomic Force Microscope
Low
Report
Bruker Introduces Dimension Nexus™ Atomic Force Microscope
11/18
07:00 am
brkr
Bruker Announces Quarterly Dividend
Medium
Report
Bruker Announces Quarterly Dividend
11/12
07:00 am
brkr
Bruker Corporation to Present at Upcoming Investor Conferences
Low
Report
Bruker Corporation to Present at Upcoming Investor Conferences
11/8
07:00 am
brkr
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
Medium
Report
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
11/6
02:10 pm
brkr
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $75.00. They now have a "buy" rating on the stock.
Low
Report
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $75.00. They now have a "buy" rating on the stock.
11/6
01:10 pm
brkr
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at TD Cowen from $72.00 to $70.00. They now have a "hold" rating on the stock.
Low
Report
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at TD Cowen from $72.00 to $70.00. They now have a "hold" rating on the stock.
11/6
11:05 am
brkr
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Wells Fargo & Company from $78.00 to $75.00. They now have an "overweight" rating on the stock.
Low
Report
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Wells Fargo & Company from $78.00 to $75.00. They now have an "overweight" rating on the stock.
11/6
09:16 am
brkr
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Barclays PLC from $75.00 to $69.00. They now have an "overweight" rating on the stock.
Medium
Report
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Barclays PLC from $75.00 to $69.00. They now have an "overweight" rating on the stock.
11/6
02:22 am
brkr
Bruker Corp (BRKR) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Margin Pressures [Yahoo! Finance]
Medium
Report
Bruker Corp (BRKR) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Margin Pressures [Yahoo! Finance]
11/5
10:05 am
brkr
Bruker (BRKR) Q3 Earnings and Revenues Lag Estimates [Yahoo! Finance]
Medium
Report
Bruker (BRKR) Q3 Earnings and Revenues Lag Estimates [Yahoo! Finance]
11/5
07:00 am
brkr
Bruker Reports Third Quarter 2024 Financial Results
Medium
Report
Bruker Reports Third Quarter 2024 Financial Results
10/28
04:05 pm
brkr
Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast
Low
Report
Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast
10/21
06:00 am
brkr
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
Low
Report
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
10/17
08:58 am
brkr
European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products
Low
Report
European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products
10/17
08:30 am
brkr
Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress
Low
Report
Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress